Selected article for: "acceptable safety apparent efficacy and chloroquine phosphate"

Author: Miyssa I. Abdelmageed; Abdelrahman H. Abdelmoneim; Mujahed I. Mustafa; Nafisa M. Elfadol; Naseem S. Murshed; Shaza W. Shantier; Abdelrafie M. Makhawi
Title: Design of multi epitope-based peptide vaccine against E protein of human COVID-19: An immunoinformatics approach
  • Document date: 2020_2_11
  • ID: 6ojmmmuj_54
    Snippet: Although both flu and anti-HIV drugs are used currently in China for treatment of COVID-19, and chloroquine phosphate, an old drug for treatment of malaria, has recently found to have apparent efficacy and acceptable safety against 79] ; nevertheless more studies are required to standardize these therapies. In addition, there has been some success in the development of mouse models of MERS-CoV and SARS-CoV infection, and candidate vaccines where .....
    Document: Although both flu and anti-HIV drugs are used currently in China for treatment of COVID-19, and chloroquine phosphate, an old drug for treatment of malaria, has recently found to have apparent efficacy and acceptable safety against 79] ; nevertheless more studies are required to standardize these therapies. In addition, there has been some success in the development of mouse models of MERS-CoV and SARS-CoV infection, and candidate vaccines where the envelope (E) protein is mutated or deleted have been described [80] [81] [82] [83] [84] [85] [86] . To best of our knowledge, this is the first study to identify certain peptides in envelope (E) protein as candidates for COVID-19. Accordingly, these epitopes were strongly recommended as promising epitopes vaccine candidate against T cell.

    Search related documents:
    Co phrase search for related documents
    • acceptable safety and candidate protein: 1, 2
    • acceptable safety and chloroquine phosphate: 1, 2
    • acceptable safety and malaria treatment: 1
    • acceptable safety and malaria treatment old drug: 1
    • acceptable safety and malaria treatment old drug chloroquine phosphate: 1
    • acceptable safety apparent efficacy and apparent efficacy: 1, 2, 3
    • acceptable safety apparent efficacy and chloroquine phosphate: 1, 2
    • acceptable safety apparent efficacy and malaria treatment: 1
    • acceptable safety apparent efficacy and malaria treatment old drug: 1
    • apparent efficacy and chloroquine phosphate: 1, 2, 3
    • apparent efficacy and malaria treatment: 1
    • apparent efficacy and malaria treatment old drug: 1
    • candidate protein and epitope vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • candidate protein and epitope vaccine candidate: 1, 2, 3, 4, 5, 6, 7, 8
    • China currently and chloroquine phosphate: 1
    • China currently and epitope vaccine: 1
    • China currently and malaria treatment: 1
    • chloroquine phosphate and malaria treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • chloroquine phosphate and malaria treatment old drug: 1, 2